Xenical Rx-To-OTC Switch In The Works, GSK/Roche Announce
This article was originally published in The Tan Sheet
Executive Summary
Roche and GlaxoSmithKline appear to be moving quickly on an Rx-to-OTC switch application for the anti-obesity agent Xenical (orlistat)